P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research

Benzer Materyaller

• The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants
  Yazar:: Volk, Jonathan E., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women
  Yazar:: Latka, Mary H., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Self-reported Benefits of Study Participation in HVTN 503, “Phambili”
  Yazar:: Allen, Mary A., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine
  Yazar:: Latka, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials
  Yazar:: Volk, JE, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)